Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Frontiers in Bioscience (Landmark Edition)
|
January 4, 2011
Theoretical and computational approaches to ligand-based drug discovery
Angelo D Favia
Molecular and Cellular Endocrinology
|
September 30, 2008
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds
Andreas Blum, Angelo D Favia, Edmund Maser
Nature Biotechnology
|
February 11, 2009
Protein promiscuity and its implications for biotechnology
Irene Nobeli, Angelo D Favia, Janet M Thornton
Plos One
|
October 4, 2011
Substrate binding process and mechanistic functioning of type 1 11β-hydroxysteroid dehydrogenase from enhanced sampling methods
Angelo D Favia, Matteo Masetti, Maurizio Recanatini, et al.
Drug Discovery Today
|
August 26, 2011
The role of fragment-based and computational methods in polypharmacology
Giovanni Bottegoni, Angelo D Favia, Maurizio Recanatini, et al.
Chemmedchem
|
November 24, 2015
The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
Giulia Palermo, Angelo D Favia, Marino Convertino, et al.
Journal of Molecular Biology
|
November 27, 2007
Molecular docking for substrate identification: the short-chain dehydrogenases/reductases
Angelo D Favia, Irene Nobeli, Fabian Glaser, et al.
Journal of Chemical Information and Modeling
|
September 23, 2011
SERAPhiC: a benchmark for in silico fragment-based drug design
Angelo D Favia, Giovanni Bottegoni, Irene Nobeli, et al.
Chemmedchem
|
December 15, 2015
Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments
Giovanni Bottegoni, Marina Veronesi, Paola Bisignano, et al.
Journal of Chemical Information and Modeling
|
December 4, 2012
In silico deconstruction of ATP-competitive inhibitors of glycogen synthase kinase-3β
Paola Bisignano, Chiara Lambruschini, Manuele Bicego, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Frontiers in Bioscience (Landmark Edition)
|
January 4, 2011
Theoretical and computational approaches to ligand-based drug discovery
Angelo D Favia
Molecular and Cellular Endocrinology
|
September 30, 2008
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds
Andreas Blum, Angelo D Favia, Edmund Maser
Nature Biotechnology
|
February 11, 2009
Protein promiscuity and its implications for biotechnology
Irene Nobeli, Angelo D Favia, Janet M Thornton
Plos One
|
October 4, 2011
Substrate binding process and mechanistic functioning of type 1 11β-hydroxysteroid dehydrogenase from enhanced sampling methods
Angelo D Favia, Matteo Masetti, Maurizio Recanatini, et al.
Drug Discovery Today
|
August 26, 2011
The role of fragment-based and computational methods in polypharmacology
Giovanni Bottegoni, Angelo D Favia, Maurizio Recanatini, et al.
Chemmedchem
|
November 24, 2015
The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
Giulia Palermo, Angelo D Favia, Marino Convertino, et al.
Journal of Molecular Biology
|
November 27, 2007
Molecular docking for substrate identification: the short-chain dehydrogenases/reductases
Angelo D Favia, Irene Nobeli, Fabian Glaser, et al.
Journal of Chemical Information and Modeling
|
September 23, 2011
SERAPhiC: a benchmark for in silico fragment-based drug design
Angelo D Favia, Giovanni Bottegoni, Irene Nobeli, et al.
Chemmedchem
|
December 15, 2015
Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments
Giovanni Bottegoni, Marina Veronesi, Paola Bisignano, et al.
Journal of Chemical Information and Modeling
|
December 4, 2012
In silico deconstruction of ATP-competitive inhibitors of glycogen synthase kinase-3β
Paola Bisignano, Chiara Lambruschini, Manuele Bicego, et al.
Page
of 3